Unknown

Dataset Information

0

The Hepatoprotection by Oleanolic Acid Preconditioning: Focusing on PPARα Activation.


ABSTRACT:

Objective

Previous studies have characterized the hepatoprotective and anti-inflammatory properties of oleanolic acid (OA). This study aimed to investigate the molecular mechanisms of OA hepatoprotection in concanavalin A- (ConA-) induced acute liver injury.

Materials and methods

ConA (20 mg/kg) was intravenously injected to induce acute liver injury in Balb/C mice. OA pretreatment (20, 40, and 80 mg/kg) was administered subcutaneously once daily for 3 consecutive days prior to treatment with ConA; 2, 8, and 24 h after ConA injection, the levels of serum liver enzymes and the histopathology of major factors and inflammatory cytokines were determined.

Results

OA reduced the release of serum liver enzymes and inflammatory factors and prevented ConA mediated damage to the liver. OA elevated the expression levels of peroxisome proliferator-activated receptor alpha (PPARα) and decreased the phosphorylation of c-Jun NH2-terminal kinase (JNK).

Conclusion

OA exhibits anti-inflammatory properties during ConA-induced acute liver injury by attenuating apoptosis and autophagy through activation of PPARα and downregulation of JNK signaling.

SUBMITTER: Wang W 

PROVIDER: S-EPMC5901823 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Hepatoprotection by Oleanolic Acid Preconditioning: Focusing on PPAR<i>α</i> Activation.

Wang Wenwen W   Chen Kan K   Xia Yujing Y   Mo Wenhui W   Wang Fan F   Dai Weiqi W   Niu Peiqin P  

PPAR research 20180402


<h4>Objective</h4>Previous studies have characterized the hepatoprotective and anti-inflammatory properties of oleanolic acid (OA). This study aimed to investigate the molecular mechanisms of OA hepatoprotection in concanavalin A- (ConA-) induced acute liver injury.<h4>Materials and methods</h4>ConA (20 mg/kg) was intravenously injected to induce acute liver injury in Balb/C mice. OA pretreatment (20, 40, and 80 mg/kg) was administered subcutaneously once daily for 3 consecutive days prior to tr  ...[more]

Similar Datasets

| S-EPMC8087947 | biostudies-literature
| S-EPMC4101680 | biostudies-literature
| S-EPMC8705357 | biostudies-literature
| S-EPMC3009164 | biostudies-literature
| S-EPMC3631429 | biostudies-literature
| S-EPMC8361479 | biostudies-literature
| S-EPMC10079514 | biostudies-literature
| S-EPMC9213889 | biostudies-literature
| S-EPMC1885989 | biostudies-literature
| S-EPMC2190030 | biostudies-other